Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
Abstract
Whole genome sequencing (WGS) promises to be transformative for the practice of clinical microbiology, and the rapidly falling cost and turnaround time mean that this will become a viable technology in diagnostic and reference laboratories in the near future. The objective of this article is to consider at a very practical level where, in the context of a modern diagnostic microbiology laboratory, WGS might be costeffective compared to current alternatives. We propose that molecular epidemiology performed for surveillance and outbreak investigation and genotypic antimicrobial susceptibility testing for microbes that are difficult to grow represent the most immediate areas for application of WGS, and discuss the technical and infrastructure requirements for this to be implemented.
MeSH terms
Funding
- Wellcome Trust
- United Kingdom Clinical Research Collaboration
- Scottish Government
- Cambridge Philosophical Society
- National Institute for Health and Care Research
- European Commission
- Astellas Pharma
- Directorate for Biological Sciences
- Chief Scientist Office, Scottish Government Health and Social Care Directorate
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- NIHR Cambridge Biomedical Research Centre
How this paper connects to the literature. Drag to explore, click any node to open that paper.
